🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Cecília G Carvalhaes

bioMérieux (Brazil)

ORCID: 0000-0002-2734-3754

Also affiliated with bioMérieux (United States)

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.832Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011–2019)

The Journal of Antibiotics(2021)10.1038/s41429-021-00431-4
Top 24%
0.832DataRank
Top 24%22 citations

Cecília G Carvalhaes, Paul R. Rhomberg, S. A. Messer, Mariana Castanheira, Michael A. Pfaller

Papers

Driven by 6 papers — median percentile 76. Top paper: “Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011–2019)”.

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011–2019)

The Journal of Antibiotics(2021)10.1038/s41429-021-00431-4
Top 24%
0.832DataRank
Top 24%22 citations

Cecília G Carvalhaes, Paul R. Rhomberg, S. A. Messer, Mariana Castanheira, Michael A. Pfaller

Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019–2021)

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad046
N/A
0DataRank · unranked
73 citations

Rodrigo E. Mendes, Cecília G Carvalhaes, John H. Kimbrough, Mariana Castanheira, Hélio S. Sader

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014–2021

Microbiology Spectrum(2023)10.1128/spectrum.01981-23
N/A
0DataRank · unranked
10 citations

Dee Shortridge, Cecília G Carvalhaes, Mariana Castanheira, Michael A. Pfaller

Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00570-24
N/A
0DataRank · unranked
32 citations

Lalitagauri M. Deshpande, Paul R. Rhomberg, Cecília G Carvalhaes, Mariana Castanheira

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01584-23
N/A
0DataRank · unranked
24 citations

Chris M. Pillar, Mariana Castanheira, Cecília G Carvalhaes, David R. Andes, Jalal A. Aram +7 more

Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021)

Journal of Clinical Microbiology(2024)10.1128/jcm.01141-23
N/A
0DataRank · unranked
21 citations

Cecília G Carvalhaes, Paul R. Rhomberg, L. M. Desphande, Mariana Castanheira, Michael A. Pfaller